OncoTargets and Therapy · 2020 · 46 citations · 19 references
MedicineMolecular BiologyOncologyGastrointestinal OncologyGene ExpressionMolecular OncologyCancer ImmunotherapyGastric CancerMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna TargetingProgrammed Cell Death Ligand 1 InhibitionProgrammed Cell Death Ligand 1 RegulationProgrammed Cell Death Ligand 1 SignalingProgrammed Death-ligand 1 Signaling
INTRODUCTION: Long non-coding RNAs (lncRNAs) have been demonstrated to participate in many biological processes and severs as important regulators during the progression of gastric cancer. METHODS: Here, we introduced human lncRNA SNHG15 which was highly expressed in gastric cancer and cells. Interestingly, the expression of SNHG15 was correlated with programmed cell death ligand 1 (PD-L1), which promotes the resistance of gastric cancer cells to immune responses. Meanwhile, SNHG15 downregulation suppressed the expression of PD-L1 and resistance of immune responses. RESULTS: Further, our results suggested that SNHG15 acted as a competing endogenous RNA (CeRNA) to sponge miR-141, which was downregulated in gastric cancers and negatively correlated to PD-L1. CONCLUSION: Our results suggested that SNHG15 improved the expression of PD-L1 by inhibiting miR-141, which in turn promoted the resistance of stomach cancer cells to the immune responses.
19